AGI program on the development of a generally accepted ataxia rating scale
4 & 5 November 2022 | Ataxia Global Conference, Dallas, TX, USA
Viewpoint: “Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective”
AGI symposium – 22 & 23 November 2021 – online
14 December 2021 | AGI YII Webinar: “Magnetic resonance imaging in clinical care and research of ataxias”
22 & 23 November 2021 | AGI symposium (online): “Getting ready for clinical trials”
9 November 2021 | ERN-RND webinar: “Clinical outcome assessments in ataxia”
17-22 September 2021 | MDS Virtual Congress
Brief report: “Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood”
Review article: “The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias”
6 July 2021 | ERN-RND webinar “Speech as a biomarker in ataxia: What can it tell us and how should we use it?”
13 April 2021 | ERN-RND webinar “MR Biomarkers in Spinocerebellar Ataxias”
10-13 March 2021 | Annual Ataxia Conference (NAF)
Launch of Critical Path to Therapeutics for the Ataxias (CPTA) Consortium
SCA & ARCA Global Conference 2020 – recorded sessions/flash talks & abstracts
24 November | ERN-RND webinar “Development of Sara-home: a novel assessment tool for patients with ataxia “